Cargando…
Pro/con clinical debate: Life support should have a special status among therapies, and patients or their families should have a right to insist on this treatment even if it will not improve outcome
Most hospitals are facing the dilemma caused by demand for critical care beds outstripping supply. This imbalance is likely to get worse over the coming years as a result of many factors, including aging of the population, improved technology, and improved therapies, among other factors. As a result...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC522828/ https://www.ncbi.nlm.nih.gov/pubmed/15312204 http://dx.doi.org/10.1186/cc2823 |
_version_ | 1782121856318308352 |
---|---|
author | Crippen, David Hawryluck, Laura |
author_facet | Crippen, David Hawryluck, Laura |
author_sort | Crippen, David |
collection | PubMed |
description | Most hospitals are facing the dilemma caused by demand for critical care beds outstripping supply. This imbalance is likely to get worse over the coming years as a result of many factors, including aging of the population, improved technology, and improved therapies, among other factors. As a result we are likely to have to make further tough decisions about rationing of this service. In this issue of Critical Care, two authors debate the appropriateness of providing life support in accordance with a family's wishes to an individual who is unlikely to survive admission to the intensive care unit. Understanding both sides of this debate is an important aspect of an intensivist's job. |
format | Text |
id | pubmed-522828 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2004 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-5228282004-10-17 Pro/con clinical debate: Life support should have a special status among therapies, and patients or their families should have a right to insist on this treatment even if it will not improve outcome Crippen, David Hawryluck, Laura Crit Care Review Most hospitals are facing the dilemma caused by demand for critical care beds outstripping supply. This imbalance is likely to get worse over the coming years as a result of many factors, including aging of the population, improved technology, and improved therapies, among other factors. As a result we are likely to have to make further tough decisions about rationing of this service. In this issue of Critical Care, two authors debate the appropriateness of providing life support in accordance with a family's wishes to an individual who is unlikely to survive admission to the intensive care unit. Understanding both sides of this debate is an important aspect of an intensivist's job. BioMed Central 2004 2004-02-19 /pmc/articles/PMC522828/ /pubmed/15312204 http://dx.doi.org/10.1186/cc2823 Text en Copyright © 2004 BioMed Central Ltd |
spellingShingle | Review Crippen, David Hawryluck, Laura Pro/con clinical debate: Life support should have a special status among therapies, and patients or their families should have a right to insist on this treatment even if it will not improve outcome |
title | Pro/con clinical debate: Life support should have a special status among therapies, and patients or their families should have a right to insist on this treatment even if it will not improve outcome |
title_full | Pro/con clinical debate: Life support should have a special status among therapies, and patients or their families should have a right to insist on this treatment even if it will not improve outcome |
title_fullStr | Pro/con clinical debate: Life support should have a special status among therapies, and patients or their families should have a right to insist on this treatment even if it will not improve outcome |
title_full_unstemmed | Pro/con clinical debate: Life support should have a special status among therapies, and patients or their families should have a right to insist on this treatment even if it will not improve outcome |
title_short | Pro/con clinical debate: Life support should have a special status among therapies, and patients or their families should have a right to insist on this treatment even if it will not improve outcome |
title_sort | pro/con clinical debate: life support should have a special status among therapies, and patients or their families should have a right to insist on this treatment even if it will not improve outcome |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC522828/ https://www.ncbi.nlm.nih.gov/pubmed/15312204 http://dx.doi.org/10.1186/cc2823 |
work_keys_str_mv | AT crippendavid proconclinicaldebatelifesupportshouldhaveaspecialstatusamongtherapiesandpatientsortheirfamiliesshouldhavearighttoinsistonthistreatmentevenifitwillnotimproveoutcome AT hawrylucklaura proconclinicaldebatelifesupportshouldhaveaspecialstatusamongtherapiesandpatientsortheirfamiliesshouldhavearighttoinsistonthistreatmentevenifitwillnotimproveoutcome |